Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
October 28, 2020 at 06:32 am EDT
Share
NanHua Bio-medicine Co. Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 104.657 million compared to CNY 90.235 million a year ago. Operating income was CNY 1.408 million compared to operating loss of CNY 19.274 million a year ago. Net loss was CNY 3.495 million compared to CNY 20.088 million a year ago. Basic loss per share from continuing operations was CNY 0.0112 compared to CNY 0.0645 a year ago.
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Company's biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Company's energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.